IBDEI1JV ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24776,1,4,0)
 ;;=4^C82.09
 ;;^UTILITY(U,$J,358.3,24776,2)
 ;;=^5001470
 ;;^UTILITY(U,$J,358.3,24777,0)
 ;;=C82.00^^107^1211^66
 ;;^UTILITY(U,$J,358.3,24777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24777,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Unspec Site
 ;;^UTILITY(U,$J,358.3,24777,1,4,0)
 ;;=4^C82.00
 ;;^UTILITY(U,$J,358.3,24777,2)
 ;;=^5001461
 ;;^UTILITY(U,$J,358.3,24778,0)
 ;;=C82.19^^107^1211^67
 ;;^UTILITY(U,$J,358.3,24778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24778,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,24778,1,4,0)
 ;;=4^C82.19
 ;;^UTILITY(U,$J,358.3,24778,2)
 ;;=^5001480
 ;;^UTILITY(U,$J,358.3,24779,0)
 ;;=C82.10^^107^1211^68
 ;;^UTILITY(U,$J,358.3,24779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24779,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Unspec Site
 ;;^UTILITY(U,$J,358.3,24779,1,4,0)
 ;;=4^C82.10
 ;;^UTILITY(U,$J,358.3,24779,2)
 ;;=^5001471
 ;;^UTILITY(U,$J,358.3,24780,0)
 ;;=C82.29^^107^1211^69
 ;;^UTILITY(U,$J,358.3,24780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24780,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,24780,1,4,0)
 ;;=4^C82.29
 ;;^UTILITY(U,$J,358.3,24780,2)
 ;;=^5001490
 ;;^UTILITY(U,$J,358.3,24781,0)
 ;;=C82.20^^107^1211^70
 ;;^UTILITY(U,$J,358.3,24781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24781,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Unspec Site
 ;;^UTILITY(U,$J,358.3,24781,1,4,0)
 ;;=4^C82.20
 ;;^UTILITY(U,$J,358.3,24781,2)
 ;;=^5001481
 ;;^UTILITY(U,$J,358.3,24782,0)
 ;;=C82.39^^107^1211^71
 ;;^UTILITY(U,$J,358.3,24782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24782,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,24782,1,4,0)
 ;;=4^C82.39
 ;;^UTILITY(U,$J,358.3,24782,2)
 ;;=^5001500
 ;;^UTILITY(U,$J,358.3,24783,0)
 ;;=C82.30^^107^1211^72
 ;;^UTILITY(U,$J,358.3,24783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24783,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Unspec Site
 ;;^UTILITY(U,$J,358.3,24783,1,4,0)
 ;;=4^C82.30
 ;;^UTILITY(U,$J,358.3,24783,2)
 ;;=^5001491
 ;;^UTILITY(U,$J,358.3,24784,0)
 ;;=C82.49^^107^1211^73
 ;;^UTILITY(U,$J,358.3,24784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24784,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,24784,1,4,0)
 ;;=4^C82.49
 ;;^UTILITY(U,$J,358.3,24784,2)
 ;;=^5001510
 ;;^UTILITY(U,$J,358.3,24785,0)
 ;;=C82.40^^107^1211^74
 ;;^UTILITY(U,$J,358.3,24785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24785,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
 ;;^UTILITY(U,$J,358.3,24785,1,4,0)
 ;;=4^C82.40
 ;;^UTILITY(U,$J,358.3,24785,2)
 ;;=^5001501
 ;;^UTILITY(U,$J,358.3,24786,0)
 ;;=C82.99^^107^1211^75
 ;;^UTILITY(U,$J,358.3,24786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24786,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,24786,1,4,0)
 ;;=4^C82.99
 ;;^UTILITY(U,$J,358.3,24786,2)
 ;;=^5001550
 ;;^UTILITY(U,$J,358.3,24787,0)
 ;;=C82.90^^107^1211^76
 ;;^UTILITY(U,$J,358.3,24787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24787,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Unspec Site
 ;;^UTILITY(U,$J,358.3,24787,1,4,0)
 ;;=4^C82.90
 ;;^UTILITY(U,$J,358.3,24787,2)
 ;;=^5001541
 ;;^UTILITY(U,$J,358.3,24788,0)
 ;;=R59.1^^107^1211^61
